ArticleFrontiers in oncology2021

SENP2 Reduces Hepatocellular Carcinoma Stemness and Improves Sorafenib Sensitivity Through Inactivating the AKT/GSK3β/CTNNB1 Pathway.

Xiaohui Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.